Skip to content

Associations between obesity-and lipid-related indices and diabetic kidney disease in patients with type 2 diabetes : a cross-sectional study

Associations between obesity-and lipid-related indices and diabetic kidney disease in patients with type 2 diabetes : a cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090626
Enrollment
Unknown
Registered
2024-10-10
Start date
2024-10-11
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Non-diabetic kidney disease:None

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Hospitalized patients aged 18-80 years who met diagnostic criteria for type 2 diabetes

Exclusion criteria

Exclusion criteria: (1) primary nephropathy, (2) acute complications of diabetes such as hypoglycemic coma, diabetic ketoacidosis, hyperglycemic hyperosmolar coma, and lactic acidosis, (3) concurrent acute or chronic infections, (4) concurrent malignant or autoimmune diseases, and (5) any organ dysfunction or failure.

Design outcomes

Primary

MeasureTime frame
Chinese Visceral Adiposity Index(CVAI);visceral adiposity index(VAI);lipid accumulation product (LAP);cardiometabolic index(CMI);

Secondary

MeasureTime frame
Height;Weight;Waist circumference;Hip circumference;Blood pressure;glycosylated hemoglobin(HbA1c);fasting blood glucose(FBG);total cholesterol(TC); triglycerides(TG);low-density lipoprotein(LDL);high-density lipoprotein(HDL);Alanine aminotransferase(ALT);Aspartate aminotransferase(AST);

Countries

China

Contacts

Public ContactQing Wang

The Affiliated Hospital of Qingdao University

627791946@qq.com+86 186 6180 8627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026